Acorda Therapeutics Financials

Acorda Therapeutics Stock Summary

Acorda Therapeutics competes with Shionogi, Pacira BioSciences,, Sunshine Biopharma, Biofrontera, and Shuttle Pharmaceuticals. Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York. Acorda Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.

Acorda Therapeutics Key Financial Ratios

Acorda Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Acorda Therapeutics's current stock value. Our valuation model uses many indicators to compare Acorda Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acorda Therapeutics competition to find correlations between indicators driving Acorda Therapeutics's intrinsic value. More Info.Acorda Therapeutics is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Acorda Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.